What's Happening?
Thermo Fisher Scientific has opened a new Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center in South San Francisco. This facility aims to provide pharmaceutical and biotechnology companies with access to advanced cryo-EM technologies, which are
crucial for accelerating drug discovery and development. The center is designed to lower the barriers to adopting cryo-EM, enabling faster and more cost-effective development of structure-guided drugs. These drugs have a higher clinical success rate and reduced preclinical time compared to traditional methods. The center builds on the success of a similar initiative in the UK and is expected to foster collaboration among industry leaders in the Bay Area.
Why It's Important?
The opening of the Cryo-EM Drug Discovery Center represents a significant advancement in the field of drug discovery, particularly in the U.S. pharmaceutical and biotechnology sectors. By providing access to cutting-edge cryo-EM technology, the center is poised to enhance the efficiency and effectiveness of developing new therapies. This can lead to faster delivery of life-saving medicines to patients, potentially transforming treatment options for various diseases. The initiative also underscores the importance of collaboration between scientific institutions and industry leaders in driving innovation and maintaining the U.S.'s competitive edge in the global pharmaceutical market.
